Internal Medicine, Interventional Cardiology · New York, NY
NPI
1447456231
Since 2007
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
139 Centre St, Suite 307
New York, NY, 10013
Phone (212) 334-3507
Groups this clinician bills Medicare through
Medicare paid, 2024
$881K
5,814 services
Medicare patients, 2024
456
Average age 77
Drug cost, 2024
$5.1M
25,996 prescriptions
Company payments, 2025
$2,295
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael C Liou was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,119 times for 435 patients. In total Michael C Liou billed 5,814 services in 71 codes, and Medicare paid $881K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-20.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,119 | 435 | $13.93 | $16K |
| 99213 Office E&M - Established | Office | 896 | 390 | $71.28 | $64K |
| 93000 Electrocardiogram | Office | 614 | 411 | $10.47 | $6,427 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 560 | 140 | $3.27 | $1,829 |
| 93306 Echocardiography (TTE/TEE) | Office | 328 | 327 | $144.53 | $47K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 317 | 315 | $167.09 | $53K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 277 | 139 | $281.16 | $78K |
| 93925 Duplex Scan - Extremity Arteries | Office | 177 | 177 | $214.06 | $38K |
| 93015 Electrocardiogram | Office | 170 | 170 | $58.25 | $9,903 |
| 78492 Myocardial Perfusion Scan | Office | 138 | 138 | $1,190.34 | $164K |
| 93978 Duplex Scan - Extremity Arteries | Office | 137 | 137 | $128.66 | $18K |
| 99212 Office E&M - Established | Office | 127 | 114 | $47.16 | $5,989 |
| 93970 Duplex Scan - Extremity Veins | Office | 103 | 102 | $163.01 | $17K |
| 99214 Office E&M - Established | Office | 89 | 78 | $109.56 | $9,751 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 64 | 32 | $27.43 | $1,756 |
By year: 2022 $1.2M for 5,193 services; 2023 $972K for 4,816 services; 2024 $881K for 5,814 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael C Liou prescribed most often to Medicare patients was Metoprolol Succinate, with 2,588 prescriptions and refills. In total Michael C Liou wrote 25,996 Medicare prescriptions that cost $5.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 2,588 | 4,360 | 555 | $21K |
| Atorvastatin Calcium Generic | 1,793 | 3,437 | 447 | $13K |
| Xarelto Rivaroxaban | 1,537 | 2,269 | 269 | $1.3M |
| Nitroglycerin Generic | 1,526 | 1,579 | 389 | $16K |
| Amlodipine Besylate Generic | 1,191 | 2,130 | 281 | $5,822 |
| Vascepa Icosapent Ethyl | 1,128 | 1,699 | 221 | $583K |
| Eliquis Apixaban | 1,084 | 1,509 | 196 | $882K |
| Losartan Potassium Generic | 967 | 1,841 | 246 | $5,811 |
| Clopidogrel Clopidogrel Bisulfate | 880 | 1,653 | 219 | $6,148 |
| Ranolazine Er Ranolazine | 655 | 1,043 | 123 | $42K |
| Gabapentin Generic | 588 | 675 | 125 | $5,217 |
| Carvedilol Generic | 548 | 1,059 | 118 | $3,369 |
| Entresto Sacubitril/Valsartan | 479 | 681 | 83 | $448K |
| Rosuvastatin Calcium Generic | 446 | 945 | 128 | $4,219 |
| Furosemide Generic | 416 | 484 | 124 | $1,121 |
Brand drugs: 7,107 claims; generic drugs: 18,857 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael C Liou $2,295 ($2,295 in general payments such as food, travel and fees) from 13 companies. The largest payer was Boston Scientific Corporation with $404.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 5 | $404 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $326 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $306 |
| Merck Sharp & Dohme LLC MRK | 12 | $251 |
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $190 |
| Cleerly, Inc. | 1 | $188 |
| Biotronik Inc. | 1 | $171 |
| Abbott Laboratories ABT | 1 | $141 |
| Medtronic, Inc. MDT | 1 | $111 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $82.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.